RESMED INC — Director's Dealing 2023

Nov 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2023-11-13

Reporting Person: Farrell Michael J. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-11-13	ResMed Common Stock	F	3232.71	$143.60	Disposed	446205	Direct
2023-11-13	ResMed Common Stock	F	3037.906	$143.60	Disposed	443167	Direct
2023-11-13	ResMed Common Stock	F	2181.29	$143.60	Disposed	440986	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ResMed Common Stock	0	Indirect
ResMed Common Stock	4090	Indirect

Footnotes

F1: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/19/2020.

F2: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/18/2021.

F3: Disposition to issuer for tax withholding on vesting of Restricted Stock Units granted on 11/16/2022.

F4: Includes 78.152 shares of ResMed stock purchased on October 31, 2023, through the ResMed Employee Stock Purchase Plan.